Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin

Pediatric Blood and Cancer

Volumn 53, Issue 1, 2009, Pages 90-91

  Watt, Tanya ^a   Warshaw, Barry ^a   Katzenstein, Howard M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Anemia; Hemolytic; Steroids; Uremic

Indexed keywords

CREATININE; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE COFACTOR PROTEIN; METHYLPREDNISOLONE; NITROGEN; PREDNISONE; STEROID; UREA; CD46 PROTEIN, HUMAN; GLUCOCORTICOID; IMMUNOLOGIC FACTOR;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE COURSE; GENE MUTATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; PLASMA TRANSFUSION; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT RESPONSE; BLOOD TRANSFUSION; GENETICS; INFANT; MALE; MUTATION; TREATMENT OUTCOME;

ANTIGENS, CD46; BLOOD TRANSFUSION; GLUCOCORTICOIDS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MALE; METHYLPREDNISOLONE; MUTATION; TREATMENT OUTCOME;

EID: 66149093078     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21951     Document Type: Article

References (11)

1. Fremeaux-Bacchi V, Moulton EA, Kavanagh D, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006;17:2017-2025. (Pubitemid 44036186)
2. Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006;108:1267-1279. (Pubitemid 44232024)
3. Zimmerhackl LB, Scheiring J, Prufer F, et al. Renal transplantation in HUS patients with disorders of complement regulation. Pediatr Nephrol 2007;22:10-16. (Pubitemid 46138353)
4. Dragon-Durey MA, Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 2005;27:359-374. (Pubitemid 41639887)
5. Cho HY, Lee BS, Moon KC, et al. Complete factor H deficiency- associated atypical hemolytic uremic syndrome in a neonate. Pediatr Nephrol 2007;22:874-880. (Pubitemid 46629624)
6. Noris M, Brioschi S, Caprioli J, et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003;362:1542-1547. (Pubitemid 37410193)
7. Richards A, Kathryn Liszewski M, Kavanagh D, et al. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol Immunol 2007;44:111-122. (Pubitemid 44754841)
8. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-755. (Pubitemid 34936657)
9. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006;354:1927-1935.
10. Bresin E, Daina E, Noris M, et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance of genetic background. Clin J Am Soc Nephrol 2006;1:88-99.
11. Michon B, Moghrabi A, Winikoff R, et al. Complications of apheresis in children. Transfusion 2007;47:1837-1842. (Pubitemid 47438550)